Euro NCAP to Launch New SAFER TRUCKS Results
WhatLatest Euro NCAP truck safety results published online and via social media.WhenTuesday 30…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
MemeCore KBW 2025 Side Event “HALLOMEME: Ride Until Next Morning” Concludes with Great Success
SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- MemeCore, the first Layer…
BYD improves Assisted Driving system in response to Euro NCAPs ATTO 3 grading
LEUVEN, BELGIUM – BYD has responded to the ’Not Recommended’ grading which…
ADVANCION PUBLISHES 2024 CORPORATE SUSTAINABILITY REPORT
Fourth annual report highlights continued progress in sustainable innovation, safety, and responsible…
Spotlight on Chery International User Summit: LEPAS to Fully Unlock Value and Invite Global Users on a Journey of Elegant Co-Creation
WUHU, China, Sept. 24, 2025 /PRNewswire/ -- From October 17–21, 2025, the Chery…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs REMONY for Advanced Health Monitoring and Heatstroke Safety
TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:…
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
izmomicro Announces Breakthrough in High-Power Motor Control Technology
BANGALORE, India, Sept. 16, 2025 /PRNewswire/ --Â izmomicro (www.izmomicro.com), a division of izmo…